TXG
10x Genomics, Inc.
NASDAQ · USHealthcareMedical - Healthcare Information Services
$43.22-1.19%
Price as of Jul 20, 2026
TXG profitability
10x Genomics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 69.6%
- EBITDA margin
- 14.6%
- EBIT margin
- -6.1%
- Net margin
- -3.5%
- Free cash flow margin
- 19.1%
Returns
- Return on equity
- -2.8%
- Return on assets
- -2.2%
- Return on invested capital
- -4.3%
- Asset turnover
- 0.62x
Cash efficiency
- Cash from operations
- $127.8M
- Cash per share
- $4.25
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.